Latest filing published 04 Nov 2026 for Xeris Biopharma Holdings, Inc..
Filing timeline
BuySaleInsider track record
Menassie Taddese: trading record in brief
Menassie Taddese is a declared insider at 2 companies; the most frequent names are Viatris Inc and Xeris Biopharma Holdings, Inc. The record holds 12 filings, for trades running from 28 February 2022 to 2 November 2026.
On the market, this insider has only sold: 1 sale, €99k in total. The rest of the record consists of 6 share grants and 5 option exercises.
On 4 November 2026 came the latest disclosure, a share grant in Xeris Biopharma Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Menassie Taddese
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,365 shares0Common StockSEC:0001867096-26-000105:0
- 8,813 shares@ US$12.0737100.0% of flowCommon StockSEC:0000899243-22-019986:0
- 34 shares@ US$10.390.2% of flowCommon StockSEC:0000899243-22-011976:1
- 80 shares0Common StockSEC:0000899243-22-011976:0
- 2,994 shares@ US$10.4817.5% of flowCommon StockSEC:0000899243-22-009540:1
- 73 shares@ US$10.480.4% of flowCommon StockSEC:0000899243-22-009540:3
- 171 shares0Common StockSEC:0000899243-22-009540:2
- 7,138 shares0Common StockSEC:0000899243-22-009540:0
- 3,218 shares@ US$11.0119.7% of flowCommon StockSEC:0000899243-22-008660:1
- 78 shares@ US$11.010.5% of flowCommon StockSEC:0000899243-22-008660:3
- 162 shares0Common StockSEC:0000899243-22-008660:2
- 6,752 shares0Common StockSEC:0000899243-22-008660:0
12 of 12 declarations
